Background: Doxorubicin is one of the most potent broad-spectrum antitumor and chemotherapeutic agents. However, it produces cardiotoxicity. Aims: . Study Design: Cell culture and animal experiment. Methods: . Furthermore, the mechanism of its cardioprotective effect was studied. Results: was due to an increase in catalase activity. Conclusion: R-(-)-carvone has synergistic anticancer action with doxorubicin on the MCF 7 cell line while decreasing its cardiotoxicity.
No takes yet. Share an insight, caveat, or question.
Abbas et al. (2020) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: